Publisher correction: antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with covid-19

HIGHLIGHTS

• who: Kara W. Chew from the (UNIVERSITY) have published the research work: Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19, in the Journal: (JOURNAL)

SUMMARY

Which incorrectly omitted from the end the following: ‘Trial Registration: ClinicalTrials.gov Identifier: NCT04518410`. @@

ACRONYMS

LAY DEFINITIONS

• adults: A person having attained full growth or maturity. Adults are of 19 through 44 years of age
• COVID-19: A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.